Creator of Blue Moon to Launch Cannabis Infused Beer | CashCropToday
0 Shares 261 Views

Creator of Blue Moon to Launch Cannabis Infused Beer

March 29, 2018
261 Views

Keith Villa the creator of the popular beer brand Blue Moon is now planning to launch his own cannabis infused beer product line. The newly founded company Ceria Beverages plans to work closely with dispensaries in legal recreational states to distribute the new product line.

The new THC infused beer will be offered in three different potency levels of THC to help accommodate their customers. Villa plans to brew beer, strip out the alcohol and then transport it to collectives to add in the THC afterwards. Though unconventional, Villa believes his new creation will revolutionize the way consumers drink beer.

Villa has partnered with Ebbu, a leading cannabinoid research company, to insure proper dosage in his new beer. Ebbu has the task of researching the specified dose of THC for a 12-ounce beverage. Their major goal is to figure out how much THC needs to be utilized that would compare to amount of  ABV found in a normal beer.

Villa compares this time in history to the prohibition of alcohol when he states, ““Back in 1933 you had a stigma with alcohol. After so many years of being illegal it took years to get over that. But once that goes away for cannabis it will be a huge part of our economy.”

You may be interested

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon
Market Watch
262 views
Market Watch
262 views

Global Hemp Group Announces Harvest Update on their CBD Hemp Farm in Scio Oregon

Editor - November 27, 2018

Vancouver, BC -- (November 27, 2018) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) and its joint venture…

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition
Global
187 views
Global
187 views

Wayland Group Enters UK Cannabis Market with Theros Pharma Acquisition

Editor - November 26, 2018

Wayland Group (CSE:WAYL) (OTCQB:MRRCF) has announced this morning that their company has entered into an agreement to acquire 51% of UK company Theros Pharma Ltd. The Wayland Group…

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials
Manufacturing
185 views
Manufacturing
185 views

GW Pharma’s CBD Pharmaceutical, Epidiolex, Shows Results in Lowering Seizures in Clinical Trials

Editor - November 26, 2018

GW Pharmaceuticals (Nasdaq: GWPH) has announced this morning that their company has completed a double-blind, placebo-controlled Phase 3 clinical trial for its Cannabidiol (CBD) derived product EPIDIOLEX®.…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: